The effects of dual anti-platelet therapy (DAPT) on neutrophil and platelet activatio

Phase 2

• Conditions: Inflammatory and Immune System - Other inflammatory or immune system disorders; Coronary artery disease; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12622001427763
• Lead Sponsor: Dr. Kathryn Hally

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-08
• Last Update Posted: 14 November 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

for the intervention arm: healthy volunteers that are aged between 45 and 70 years
for the treatment-naive arm: healthy volunteers that are aged between 18 and 70 years

Exclusion Criteria

•known cardiovascular or inflammatory disease,
•known disorder associated with platelet dysfunction or bleeding,
•participant is pregnant
•participant has Type II diabetes
•participant has history of adverse drug reaction
•participant has been treated with cardiovascular and/or immune-modulating drugs and/or antiplatelet agents within 7 days prior to recruitment

Study & Design

• Study Type: Interventional
• Study Design: Not specified